Literature DB >> 8112832

Peritoneal lavage fluid alters patterns of eicosanoid production in murine bone marrow-derived and peritoneal macrophages: dependency on inflammatory state of the peritoneum.

S E Wenzel1, J B Trudeau, D W Riches, J Y Westcott, P M Henson.   

Abstract

Murine resident macrophages produce an abundance of eicosanoids, whereas elicited macrophages produce lesser quantities of eicosanoids in general, and leukotriene C4 (LTC4) and prostacyclin (PGI2) in particular. Macrophage precursors derived from bone marrow cells produce even smaller amounts. We postulated that these differences may be regulated by substances found in the microenvironment of the cell, which may alter arachidonate release from phospholipid and its subsequent metabolism to eicosanoids. To examine if inherent differences in phospholipid availability contributed to the observed differences in eicosanoid synthesis among these three groups of macrophages, we monitored uptake and release of arachidonic acid (AA) in resident and elicited peritoneal macrophages and in bone marrow-derived macrophages (BMDM). Although differences existed in the extent of arachidonate release (37% vs. 22% vs. 27% release), the differences were not enough to explain the much larger differences in eicosanoid production. We therefore determined whether the AA cascade enzymes, including phospholipase A2 (PLA2) were intact by adding exogenous AA to the three cell types. PGI2 synthesis was not significantly increased in either elicited or BMDM. However, the enzymes necessary for LTC4 production appeared intact in elicited cells but not in BMDM. To further characterize the differences in eicosanoid synthesis between resident and elicited peritoneal macrophages and BMDM, we determined if a variety of exogenous substances [growth factors, cytokines, and noninflammatory and inflammatory peritoneal lavage fluid (NPLF and IPLF)] could enhance the production of LTC4 and PGI2 in those macrophage groups. The addition of granulocyte-macrophage colony stimulating factor (GM-CSF) slightly increased LTC4 production by BMDM and elicited macrophages. In contrast, NPLF increased the production of both LTC4 and PGI2 from BMDM, while IPLF had no effect. A similar effect of NPLF was seen on LTC4 (but not PGI2) production from elicited peritoneal cells, while IPLF decreased both LTC4 and PGI2 production from resident peritoneal macrophages. These studies indicate that substances found in the peritoneum of mice can enhance or diminish the production of LTC4 and PGI2 from the macrophage. This regulation appears to depend on the inflammatory state of the peritoneum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112832     DOI: 10.1007/bf00920478

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Monocyte migration explains the changes in macrophage arachidonate metabolism during the immune response.

Authors:  C S Tripp; E R Unanue; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung.

Authors:  M Peters-Golden; R W McNish; R Hyzy; C Shelly; G B Toews
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

3.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

4.  A quantitative evaluation of pulmonary macrophage kinetics.

Authors:  A Blussé van Oud Alblas; H Mattie; R van Furth
Journal:  Cell Tissue Kinet       Date:  1983-05

5.  The modulation of prostaglandin synthesis by peritoneal fluids.

Authors:  D M Strickland; A T Bombard; J F Trabal; M D Mitchell
Journal:  Prostaglandins       Date:  1990-09

6.  Measurement of peptidoleukotrienes in biological fluids.

Authors:  J Y Westcott; K Johnston; R A Batt; S E Wenzel; N F Voelkel
Journal:  J Appl Physiol (1985)       Date:  1990-06

7.  Indomethacin in vivo increases the sensitivity to Listeria infection in mice. A possible role for macrophage thromboxane A2 synthesis.

Authors:  C S Tripp; P Needleman; E R Unanue
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

8.  Measurement by radioimmunoassay of prostaglandins as their methyl oximes.

Authors:  R W Kelly; S Deam; M J Cameron; R F Seamark
Journal:  Prostaglandins Leukot Med       Date:  1986-09

9.  Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.

Authors:  J F DiPersio; P Billing; R Williams; J C Gasson
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

10.  Dynamics of leukotriene C production by macrophages.

Authors:  C A Rouzer; W A Scott; A L Hamill; Z A Cohn
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  4 in total

1.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus.

Authors:  A J Bune; A R Hayman; M J Evans; T M Cox
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

2.  Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype.

Authors:  Paul C Norris; Donna Reichart; Darren S Dumlao; Christopher K Glass; Edward A Dennis
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

3.  Prostaglandin I(2) analogues enhance growth-related oncogene-alpha expression in human monocyte-derived dendritic cells.

Authors:  Chang-Hung Kuo; Ren-Long Jan; Yu-Te Chu; Wei-Li Wang; Ming-Yii Huang; Ching-Hua Huang; Tai-Heng Chen; Chih-Hsing Hung
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

4.  Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation.

Authors:  Brigitte I Frohnert; Eric K Long; Wendy S Hahn; David A Bernlohr
Journal:  Diabetes       Date:  2013-09-23       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.